SUMMARY Two patients with chronic sarcoid myopathy are described. Both were middle-aged females and both showed the features of pseudohypertrophy. In other aspects they contrasted markedly. In one (A.R.) the sheer volume of granuloma and its effect on muscle fibres was sufficient to explain the muscle weakness and electromyography confirmed a pure myopathy. In the other (J.W.) the muscle granuloma was sparsely distributed and an associated neuropathy contributed importantly to the disability. There was no clinical evidence of sarcoidosis of other organs in one (A.R.) but necropsy showed multisystem involvement. There was clinical and radiographic evidence of widespread sarcoidosis in the other (J.W.). Both patients showed an initial dramatic response to prednisolone. The reported literature of symptomatic muscle sarcoidosis is reviewed briefly.
While asymptomatic involvement of skeletal muscle in sarcoidosis is sufficiently common to make muscle biopsy one of the accepted methods of tissue diagnosis (Myers et al., 1952;  Phillips and Phillips, 1956; Wallace et al., 1958) , symptomatic involvement is rare and only 44 cases have been recorded. There are three main clinical groups:
1. Muscle pain and tenderness due to acute myositis may occur in the early stages of sarcoidosis (Silverstein and Siltzbach, 1969) . The symptoms are rapidly controlled by corticosteroid therapy and there is no relapse on withdrawal provided treatment has been sufficiently prolonged (about six months as a rule).
2. Palpable muscle nodules, the first form of muscle sarcoidosis to be reported (Licharew, 1908) but the least common, may present with pain and stiffness or muscle cramps (Bates and Walsh, 1948; Eguro and Yabuki, 1966) . Muscle weakness may not be a feature during the active phase of this form of the disease but can be conspicuous later if contractures occur (Snorrason, 1947) . It is possible that some of the cases recorded were, in fact, examples of skin and subcutaneous tissue involvement along with asymptomatic muscle involvement (Silverstein et al., 1969) .
3. Symptomatic muscle sarcoidosis may pre-1034 sent as a chroniic myopathy, with bilateral weakness and wasting of the proximal muscles of the extremities and of the trunk and neck muscles, the clinical picture resembling that of muscular dystrophy (Devic et al., 1955; Ammitzboll, 1956; McConkey, 1958; Erbsloh and Dietel, 1959; Harvey, 1959; Kryger and R0nnov-Jessen, 1959; Brun, 1961; Crompton and MacDermot, 1961; Hinterbuchner and Hinterbuchner, 1964; Hofstetter, 1967; Talbot, 1967 Treatment with prednisolone was begun in a dosage of 20 mg daily. This had a dramatic effect and within a week the patient, who had previously had difficulty in standing, was able to walk short distances. By the end of a month she had virtually regained normal muscular power. The muscle pain subsided rapidly and after two weeks the pseudohypertrophy was no longer evident. Over the next six months improvement was maintained on regular treatment with prednisolone in a dosage of 10 mg daily, but in June 1965 there was slight but definite deterioration in muscular power after a reduction in the dosage of prednisolone to 7 5 mg daily which was made because of severe persisting dyspepsia and ulcer-type pain occurring in association with a sliding hiatus hernia. The deterioration was rapidly controlled by increasing the dose of prednisolone, but by October epigastric pain and dyspepsia had again become so distressing that a further reduction in the dosage of prednisolone was attempted. This was followed by severe relapse of muscle symptoms and it was necessary to readmit the patient to hospital in December 1965. The leg muscles were painful, weak, and swollen, the proximal muscles of the upper limbs were also very weak, and there was now persisting fever and a raised serum globulin. Despite increase in the dosage of prednisolone to 20 mg daily the patient became weaker. Dyspnoea developed, raising the possibility of involvement of the muscles of respiration. The cerebrospinal fluid (CSF) was examined at this time and was normal. The patient died suddenly in February 1966 with the clinical features of massive pulmonary embolism.
At necropsy pulmonary embolism was confirmed. The voluntary muscles (Fig. 2 ) and the liver were involved extensively by active sarcoidosis and sarcoid follicles were also demonstrated in the spleen, bones, tongue, and lymph nodes. The central nervous system was normal. The kidneys showed epithelial proliferation in a few of the glomeruli with thickening of the basement membranes consistent with previous glomerulonephritis. The most conspicuous renal abnormality, however, was the presence of hyaline droplets in the cytoplasm of the convoluted tubules (Fig. 3 ). These were eosinophilic, stained brightly red with Picro-Mallory and yellow with Van Gieson, were PAS negative, and did not show metachromia with Cresyl-Echt Violet. The droplets were thought to be protein in the process of transport through the tubular cells and it seemed possible that myoglobin may have contributed to their formation, since the breakdown of muscle fibres was so marked and widespread. In contrast with the initial histological appearances, the skeletal muscle fibres at necropsy were grossly abnormal and showed the features of atrophy and degeneration.
An association has been suggested between myocardial and skeletal muscle sarcoidosis (Powell-1953) apparently normal muscle fibres, were scanty and, histologically, the extent of the muscle involvement was not commensurate with the severity of the muscular weakness (Fig. 4) . Since there was no muscle atrophy, it was evident that the associated neuropathy contributed importantly. An electrocardiogram (ECG) showed sinus rhythm and evidence of left ventricular hypertrophy. There was radiological enlargement of the heart, the CT ratio being 170/270. Aspartate aminotransferase and hydroxybutyrate dehydrogenase levels were normal in the blood on three occasions. A barium swallow showed normal peristalsis. The serum electrolytes, bilirubin, alanine and aminotransferase, and alkaline phosphatase were normal. The serum creatinine was 96 mg/100 ml., calcium 9 7 mg/100 ml., and phosphate 3-2 mg/100 ml. The electrophoretic pattern of plasma proteins was normal and the antinuclear factor was present in the blood on one occasion.
During the course of investigations the bilateral parotid swelling subsided spontaneously and the legs became less swollen and painful, although there was no improvement in the muscular weakness which was most marked in the thighs. Treatment with frusemide resulted in a marked diuresis and cleared the peripheral oedema. Corticosteroid therapy was begun with prednisolone in a dosage of 20 mg daily, which resulted in very satisfactory clinical improvement. The residual swelling of the legs subsided slowly over four weeks and the leg and abdominal muscles steadily regained their power. As tone returned to the recti the protuberance of the abdomen subsided. The subcutaneous tissue swellings of the fingers slowly improved. On discharge from hospital in October 1971 the patient was able to walk freely.
At review in late November muscular power in both legs had completely returned to normal and the abdominal muscles had recovered normal power. The lower limb tendon reflexes were, however, still absent. It was interesting that ventilatory function was normal (FEV1 2,400 ml., FVC 3,100 ml.), suggesting that there may have been initial involvement of respiratory muscles which improved with treatment.
The muscle sarcoidosis continued to be well controlled on maintenance treatment with prednisolone, now reduced to 17 5 mg daily, but in February 1972 the patient began to complain of impairment of vision in the right eye and investigation showed vitreous opacities and numerous peripheral superficial retinal haemorrhages attributed to the development of vasculitis, the appearances being very similar to those of Eales's disease (Fig. 5) . The left eye showed only a few haemorrhagic spots. It seemed most probable that the retinal changes were an expression of the sarcoid process which was not being completely suppressed by prednisolone. On this account the dosage was increased temporarily to 30 mg, with subsequent improvement.
At one stage during follow-up the pulse was noted to be grossly irregular in time and force and a clinical diagnosis of atrial fibrillation was made, but by the time an ECG was obtained the rhythm had reverted to sinus. The patient continues to require large doses of diuretics to control peripheral oedema which is fairly certainly of cardiac origin. Whether or not it is aetiologically related to sarcoid involvement of the heart muscle is a matter for speculation. All other sarcoid features are under excellent control on treatment with prednisolone 20 mg daily.
DISCUSSION
The pathogenesis of symptomatic muscle sarcoidosis is obscure and why it is that the presence of granuloma should be associated with symptoms in some cases but is wholly asymptomatic in the vast majority is not known. Muscle lesions can occur in the course of systemic sarcoidosis long before a myopathic picture develops (Coers and Carbone, 1966) , but the reason for the disease process becoming dominant in skeletal muscles remains a mystery. It has been suggested that previous non-sarcoid muscle disease may predispose but this is not borne out by most case histories. The predilection for menopausal women has led to speculation about an endocrine factor but there is no proof of this (Hinterbuchner et al., 1964) .
The extent of granuloma formation in the myopathic forms of muscle sarcoidosis can vary greatly and this is well demonstrated in the two patients reported here. In the first (A.R.) the volume of granuloma alone and its effect on muscle fibres was sufficient to explain the muscular weakness, and the absence of clinical or EMG evidence of neuropathy indicated a pure myopathy. The CSF was normal. In the second (J.W.) the granuloma was sparsely distributed and the muscle fibres showed no histological abnormality but there was definite clinical and EMG evidence of associated neuropathy. There was also CSF abnormality indicating involvement of the central nervous system. Nevertheless in these two cases the clinical picture was remarkably similar and the evidence of pseudohypertrophy was equally pronounced. It is unusual for the granulomatous process to be so marked as it was in patient A.R.; in general, disability in symptomatic muscle sarcoidosis depends more on muscle atrophy and nervous system involvement than on the extent of granulomatous change.
In patient J.W. the evidence of cardiac abnormality developing coincident with florid widespread sarcoid phenomena suggests a common aetiology and supports Powell's contention that in chronic sarcoid myopathy cardiac involvement frequently coexists (Powell, 1953) .
Had there been no necropsy, patient A.R. might have been added to the 22 cases reported in the literature as isolated sarcoidosis of skeletal muscle (Devic et al., 1955; Ammitzboll, 1956; Erbsloh and Dietel, 1959; Harvey, 1959; Kryger and Ronnov-Jessen, 1959; Crompton and MacDermot, 1961; Hinterbuchner and Hinterbuchner, 1964; Coers and Carbone, 1966; Talbot, 1967) . Isolated muscle sarcoidosis has, however, never been confirmed by necropsy and it is doubtful if such an entity exists.
The place of muscle biopsy in sarcoidosis is now limited. Although muscle biopsy may give a histological diagnosis in 50 to 800/,, of patients with early sarcoidosis (Myers et al., 1952; Maurice, 1955; Phillips and Phillips, 1956; Wallace et al., 1958 ) the procedure has largely been made superfluous by the Kveim test and can now rarely be justified. Muscle biopsy has not been used routinely in the diagnosis of chronic sarcoidosis and its value in this context is not known. Muscle biopsy, however, plays a definitive role in symptomatic muscle sarcoidosis. Any non-familial muscular dystrophy should be considered for muscle biopsy (Rothfeld and Folk, 1962) . Other conditions which may on occasion be simulated by chronic sarcoid polymyositis are myasthenia gravis (Devic et al., 1955) , dermatomyositis (Weinberger, 1933) , progressive muscular atrophy (deMorsier et al., 1954) , and, when there are associated joint symptoms, Still's disease (Castellanos and Galan, 1946 
